Pharmafile Logo
Pharmafocus logo
Advanced Search

BioGen to acquire Human Immunology Biosciences for $1.15bn

May 23, 2024
Business Services Biogen, HI-Bio, Immunology, acquisition, immunology

BioGen and Human Immunology Biosciences (HI-Bio) have announced that they have entered into a definitive agreement for Biogen to acquire …

News

Merck to acquire Mirus Bio for $600m

May 23, 2024
Business Services Merck, Pharmacy, acquisition, gene therapies

Merck has announced that it has signed a definitive agreement to acquire Mirus Bio for $600m.

News

Rare disease clinical trials: the urgent need for patients to be heard

May 22, 2024
Alexion, Pharmafocus, Rare Diseases, clinical trials, feature

Ahead of Clinical Trials Day, Soraya Bekkali, from Alexion, AstraZeneca Rare Disease, highlights the urgent need to elevate patients’ voices …

Feature

Sustainability in pharma

May 22, 2024
Pharmacy, Pharmafocus, feature, sustainability

Betsy Goodfellow from Pharmafocus considers the need for sustainable practices in the pharma industry and assesses various sustainable advances that have already …

Feature

Sanofi, Formation Bio and OpenAI enter AI collaboration

May 22, 2024
Research and Development Formation Bio, OpenAI, Pharmacy, Sanofi, collaboration

Sanofi, Formation Bio and OpenAI have announced that they have entered into a collaboration with the aim of building AI-powered …

News

Eli Lilly shares positive results from phase 3 VIVID-1 trial of Crohn’s disease treatment

May 22, 2024
Medical Communications Crohn’s disease, Eli Lilly, Endocrinology, clinical trial, mirikizumab

Eli Lilly has announced results from its pivotal phase 3 VIVID-1 study, which assessed patients with moderately to severely active …

News

GSK shares positive results from phase 3 asthma trials

May 21, 2024
Research and Development Asthma & COPD, GSK, asthma, clinical trial

GSK has announced positive headline results from its phase 3 SWIFT-1 and SWIFT-2 trials, which evaluated the safety and efficacy …

News

J&J’s Tremfya meets primary and secondary endpoints in UC maintenance study

May 21, 2024
Medical Communications Gastrointestinal tract, J&J, Johnson & Johnson, clinical trial, ulcerative colitis

Johnson & Johnson (J&J) has announced the first data from its phase 3 QUASAR maintenance study which assessed Tremfya (guselkumab) …

News

AstraZeneca to build $1.5bn ADC facility in Singapore

May 20, 2024
Manufacturing and Production ADCs, AstraZeneca, Oncology, antibody drug conjugate, manufacturing

AstraZeneca has announced that it intends to build a $1.5bn manufacturing facility in Singapore, Singapore, for antibody drug conjugates (ADCs), …

News

ERS Genomics and IRBM sign license agreement for CRISPR/Cas9

May 20, 2024
Research and Development CRISPR/Cas9, ERS Genomics, IRBM, License Agreement, Pharmacy

ERS Genomics and IRBM have announced that they have entered into a non-exclusive CRISPR/Cas9 license agreement, granting IRBM access to …

News

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

May 17, 2024
Medical Communications Amgen, FDA, Oncology, lung cancer

Amgen has announced that the US Food and Drug Administration (FDA) has approved Imdelltra (tarlatamab-dlle) for the treatment of adult …

News
diana-polekhina-zbsthwt9vlc-unsplash_2

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

May 17, 2024
Research and Development AstraZeneca, COVID-19, Immunology, clinical trial

AstraZeneca has announced positive high-level results from the SUPERNOVA phase 3 trial for a COVID-19 pre-exposure prophylaxis treatment, sipavibart (formerly …

News

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024
Research and Development AMR, Fleming Initiative, GSK, Microbiology, funding

GSK has announced that it has pledged £45m to the Fleming Initiative, becoming the first founding partner of the innovative …

News

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024
Research and Development NeuroSense, Neurology, als, clinical trials

NeuroSense has announced that it has partnered with PhaseV for its upcoming phase 3 trial of PrimeC as a treatment …

News

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024
Research and Development AstraZeneca, BenevolentAI, Cardiology, collaboration, heart failure

BenevolentAI has announced that AstraZeneca has added a novel heart failure target to its discovery portfolio following the two companies’ …

News

FDA approves Roche’s HPV self-collection screening option

May 15, 2024
Medical Communications FDA, HPV, Oncology, Roche, cervical cancer

Roche has announced that the US Food and Drug Administration (FDA) has approved its human papillomavirus (HPV) self-collection solution. This …

News

NHS accepts Pfizer’s tafamidis for ATTR-CM treatment

May 14, 2024
Medical Communications ATTR-CM, Cardiology, NHS, Pfizer, tafamidis

NHS England has announced that it has accepted Pfizer’s drug, tafamidis, for the treatment of transthyretin amyloidosis cardiomyopathy (ATTR-CM).

News

Fulcrum Therapeutics and Sanofi enter collaboration for facioscapulohumeral muscular dystrophy treatment

May 14, 2024
Research and Development Musculo-skeletal disorder, Sanofi, collaboration, fulcrum therapeutics, muscular dystrophy

Fulcrum Therapeutics has announced that it has entered into a collaboration and license agreement with Sanofi for the development and …

News

PharmaTimes Medical & Scientific Excellence Awards and Nursing Industry Excellence Awards are open for entry

May 13, 2024
Business Services MSEA, NIEA, PharmaTimes, awards

Both awards are open for entry until 17 May 2024 and the live awards ceremony will take place on 11 …

News
Press release

Sanofi adds €1bn funding for biomanufacturing projects in France

May 13, 2024
Business Services Biomanufacturing, Pharmacy, Sanofi, funding, investment

Sanofi has announced that it has made a new investment of at least €1bn for the creation of new bioproduction …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025